Chronic inflammatory demyelinating polyneuropathy after autologous peripheral blood stem cell transplantation [2]

Journal of the Peripheral Nervous System

Volumn 10, Issue 4, 2005, Pages 384-385

  Peters, Gary ^a,b   Larner, Andrew J ^b  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b Walton Center for Neurology and Neurosurgery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; ETOPOSIDE; IMMUNOGLOBULIN A; PARAPROTEIN; THALIDOMIDE;

ADULT; ANEMIA; AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; CASE REPORT; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ERYTHROCYTE SEDIMENTATION RATE; HUMAN; LETTER; LOW BACK PAIN; MALE; MULTIPLE MYELOMA; NEUROLOGIC EXAMINATION; PARESTHESIA; PRIORITY JOURNAL; AUTOTRANSPLANTATION; METHODOLOGY; MIDDLE AGED; NERVE CONDUCTION; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PHYSIOLOGY; POLYRADICULONEUROPATHY; REACTION TIME; TIME;

HUMANS; MALE; MIDDLE AGED; NEURAL CONDUCTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POLYRADICULONEUROPATHY, CHRONIC INFLAMMATORY DEMYELINATING; REACTION TIME; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS;

EID: 33644845777     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/j.1085-9489.2005.00052.x     Document Type: Letter

References (9)

1. Adams C August CS Maguire H Sladky JT ( 1995). Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 12 : 58 61.
2. Boiron JM Ellie E Vital A Marit G Reme T Vital C Broustet A Reiffers J ( 1994). Peripheral neuropathy after autologous blood stem cell transplantation for multiple myeloma. Leukemia 8 : 322 326.
3. Cavaletti G Beronio A Reni L Ghiglione E Schenone A Briani C Zara G Cocito D Isoardo G Ciaramitaro P Plasmati R Pastorelli F Frigo M Piatti M Carpo M ( 2004). Thalidomide sensory neurotoxicity: a clinical and neurophysiologic study. Neurology 62 : 2291 2293.
4. Chave TA Finlay AY Knight AG All-Wales Dermatology Audit Committee ( 2001). Thalidomide usage in Wales: the need to follow guidelines. Br J Dermatol 144 : 310 315.
5. Powell RJ Gardner-Medwin JM ( 1994). Guideline for the clinical use and dispensing of thalidomide. Postgrad Med J 70 : 901 904.
6. Rabinstein AA Dispenzieri A Micallef IN Inwards DJ Litzow MR Wijdicks EF ( 2003). Acute neuropathies after peripheral blood stem cell and bone marrow transplantation. Muscle Nerve 28 : 733 736.
7. Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force ( 1991). Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Neurology 41 : 617 618.
8. Said G ( 2002). Chronic inflammatory demyelinative polyneuropathy. J Neurol 249 : 245 253.
9. Zeldis JB Williams BA Thomas SD Elsayed ME ( 1999). S.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. Clin Ther 21 : 319 330.